Zhang R - Search Results

1

Myeloid/lymphoid neoplasm with CEP110-FGFR1 fusion: An analysis of 16 cases show common features and poor prognosis.

Chen M, Wang K, Cai X, Zhang X, Chao H, Chen S, Shen H, Wang Q, Zhang R. Chen M, et al. Among authors: zhang r, zhang x. Hematology. 2021 Dec;26(1):153-159. doi: 10.1080/16078454.2020.1854493. Hematology. 2021. PMID: 33491601 Free article.

2

Analysis of JAK2(V617F) mutation in Chinese patients with myeloproliferative disorders.

Chen S, Fei H, Zhang R, Xue Y, Pan J, Wu Y, Ceng J. Chen S, et al. Among authors: zhang r. Am J Hematol. 2007 Jun;82(6):458-9. doi: 10.1002/ajh.20872. Am J Hematol. 2007. PMID: 17266061 Free article.

3

[The clinical implication of JAK2 mutation expression in patients with myeloproliferative disorders].

Fei HR, Zhang R, Chen SN, Pan JL, Cen JN, Xue YQ. Fei HR, et al. Among authors: zhang r. Zhonghua Nei Ke Za Zhi. 2007 Apr;46(4):271-3. Zhonghua Nei Ke Za Zhi. 2007. PMID: 17637260 Chinese.

4

[Quantitative analysis for JAK2 mutation in 98 patients with essential thrombocythemia and its clinical significance].

Chao HY, Shen YM, Zhang R, Feng YF, Cen JN, Yao L, Shen HJ, Zhu ZL, Xue YQ. Chao HY, et al. Among authors: zhang r. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):665-9. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009. PMID: 19549384 Chinese.

5

[The quantitative assay and clinical significance of JAK2V617F mutation in 131 patients with chronic myeloproliferative disorders].

Shen YM, Chao HY, Zhang R, Feng YF, Cen JN, Yao L, Shen HJ, Zhu ZL, Xue YQ. Shen YM, et al. Among authors: zhang r. Zhonghua Nei Ke Za Zhi. 2009 Feb;48(2):140-3. Zhonghua Nei Ke Za Zhi. 2009. PMID: 19549471 Chinese.

6

[Detection of JAK2V617F mutation and its clinical significance in 80 patients with M2 acute myelogenous leukemia].

Shen YM, Chao HY, Zhang R, Li WY, Feng YF, Zhu ZL, Xue YQ. Shen YM, et al. Among authors: zhang r. Zhonghua Zhong Liu Za Zhi. 2009 May;31(5):366-70. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19799086 Chinese.

7

[A quantitative assay for JAK2 mutation in 135 patients with chronic myeloproliferative neoplasms].

Chao HY, Shen YM, Zhang R, Feng YF, Cen JN, Yao L, Shen HJ, Zhu ZL, Xue YQ. Chao HY, et al. Among authors: zhang r. Zhonghua Xue Ye Xue Za Zhi. 2009 May;30(5):321-5. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 19799128 Chinese.

8

[Detection and clinical significance of JAK2 mutation in 412 patients with chronic myeloproliferative neoplasms].

Chao HY, Fan Z, Zhang R, Shen YM, Chen W, Fei HR, Zhu ZL, Feng YF, Chen ZX, Xue YQ. Chao HY, et al. Among authors: zhang r. Zhonghua Zhong Liu Za Zhi. 2009 Jul;31(7):510-4. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19950698 Chinese.

9

[Analysis of IDH1 and IDH2 mutations in patients with acute myeloid leukemia].

Jia ZX, Zhou M, Chao HY, Lu XZ, Zhang R, Cen L, Xiao R, Jiang NK. Jia ZX, et al. Among authors: zhang r. Zhonghua Xue Ye Xue Za Zhi. 2012 May;33(5):397-401. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22781800 Chinese.

10

[Multivariate analysis of imatinib resistance-related factors during the treatment of chronic myeloid leukemia].

Zhou M, Qiu HY, He GS, Xu Y, Cen JN, Pan JL, Chen SN, Sun AN, Zhang R, Wu DP. Zhou M, et al. Among authors: zhang r. Zhonghua Xue Ye Xue Za Zhi. 2013 May;34(5):395-8. doi: 10.3760/cma.j.issn.0253-2727.2013.05.004. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23688748 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,952 results

Search Page

Filters